RIMADYL
LOE ApproachingNDAORALTABLET
Approved
Dec 1987
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
2/8 — Basic
RIMADYL by Roche is clinical pharmacology carprofen is a non-narcotic, non-steroidal anti-inflammatory agent with characteristic analgesic and antipyretic activity approximately equipotent to indomethacin in animal models. First approved in 1987.
Drug data last refreshed 2d ago · AI intelligence enriched 3w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
RIMADYL (carprofen) is a non-narcotic, non-steroidal anti-inflammatory agent approved in 1987 for pain and inflammation management via oral tablet administration. It works by selectively inhibiting COX-2 cyclooxygenase to reduce inflammatory prostaglandins while demonstrating analgesic and antipyretic activity equipotent to indomethacin in animal models. The drug is indicated for veterinary use, primarily in dogs for musculoskeletal pain and post-operative pain management.
LOE Approaching
Product approaching loss of exclusivity with moderate competitive pressure (30%), indicating potential team downsizing or strategic repositioning initiatives.
Mechanism of Action
CLINICAL PHARMACOLOGY Carprofen is a non-narcotic, non-steroidal anti-inflammatory agent with characteristic analgesic and antipyretic activity approximately equipotent to indomethacin in animal models. The mechanism of action of carprofen, like that of other NSAIDs, is believed to be associated…
Worked on RIMADYL at Roche? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.